JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle

Area of Science:

• Cell Biology
• Epigenetics
• Muscle Development

Background:

• JARID2 is a noncatalytic component of Polycomb Repressive Complex 2 (PRC2).
• PRC2 mediates histone 3 lysine 27 (H3K27) methylation, a key epigenetic mark.
• Skeletal muscle cell proliferation and differentiation are tightly regulated processes.

Purpose of the Study:

• To investigate the role of JARID2 and PRC2 in regulating the cell cycle of skeletal muscle cells.
• To identify the downstream targets of JARID2-mediated PRC2 activity in this context.
• To elucidate the mechanism by which JARID2 controls skeletal muscle proliferation and mitotic exit.

Main Methods:

• Stable and transient depletion of JARID2 in skeletal muscle cells.
• Analysis of cell cycle progression (e.g., S phase accumulation).
• Quantitative analysis of gene expression for cell cycle regulators (cyclin D1, cyclin E1) and RB1.
• Chromatin immunoprecipitation (ChIP) to assess H3K27 methylation status.

Main Results:

• JARID2 depletion leads to increased skeletal muscle cell proliferation and S phase accumulation.
• JARID2 directly represses cyclin D1 and cyclin E1 expression via H3K27 methylation.
• Retinoblastoma protein (RB1) is a direct target of JARID2 and PRC2.
• RB1 ectopic expression can suppress cyclin D1 in JARID2-depleted cells, but RB1 depletion alone does not activate proliferation.

Conclusions:

• JARID2 and PRC2 precisely regulate skeletal muscle proliferation by repressing cyclin D1.
• JARID2-mediated repression of RB1 is crucial for mitotic exit and terminal differentiation.
• The interplay between JARID2, PRC2, cyclin D1, and RB1 is essential for controlling skeletal muscle cell fate.